- List
- By Topic
- On Map
- Search Details

"VLDLR-associated cerebellar hypoplasia" [DISEASE] OR "Cerebellar Ataxia" [DISEASE] OR NCT00041600 [ID-NUMBER]
Need help? See RSS Feeds
Choose a feed type:

"VLDLR-associated cerebellar hypoplasia" [DISEASE] OR "Cerebellar Ataxia" [DISEASE] OR NCT00041600 [ID-NUMBER] (194 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
101 | NCT01037777 | Unknown † | RISCA : Prospective Study of Individuals at Risk for SCA1, SCA2, SCA3, SCA6, SCA7 |
|
Observational |
|
Other |
|
60 | All | 18 Years to 70 Years (Adult, Senior) | NCT01037777 | C08-37 | RISCA | May 2009 | December 23, 2009 | January 31, 2012 |
|
||||||
102 | NCT01060371 | Recruiting | Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias |
|
|
Observational |
|
Other |
|
|
800 | All | 6 Years and older (Child, Adult, Senior) | NCT01060371 | IRB201700740 505-2009 |
April 2010 | June 2018 | June 2018 | February 2, 2010 | August 21, 2017 |
|
|||
103 | NCT03090789 | Recruiting | FA Clinical Outcome Measures |
|
Observational |
|
Other |
|
|
1500 | All | 4 Years to 80 Years (Child, Adult, Senior) | NCT03090789 | 01-002609 | FA-COMS | January 1, 2001 | January 1, 2030 | January 1, 2030 | March 27, 2017 | February 9, 2018 |
|
|||
104 | NCT01811706 | Completed Has Results |
Dalfampridine and Gait in Spinocerebellar Ataxias |
|
|
Interventional | Not Applicable |
|
Other / Industry |
|
|
20 | All | 18 Years and older (Adult, Senior) | NCT01811706 | 20121107 1133511 |
February 2013 | December 2013 | December 2013 | March 14, 2013 | January 12, 2015 | January 12, 2015 |
|
|
105 | NCT01096095 | Withdrawn | Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3 |
|
|
Interventional | Phase 2 |
|
Other |
|
|
0 | All | 16 Years to 80 Years (Child, Adult, Senior) | NCT01096095 | CONEP CAAE 0527.0.001.000-07 | June 2010 | December 2010 | July 2011 | March 30, 2010 | August 17, 2012 |
|
||
106 | NCT02960893 | Active, not recruiting | Trial in Adult Subjects With Spinocerebellar Ataxia |
|
|
Interventional | Phase 2 Phase 3 |
|
Industry / Other |
|
|
120 | All | 18 Years to 75 Years (Adult, Senior) | NCT02960893 | BHV4157-201 | December 2016 | August 18, 2017 | August 2018 | November 10, 2016 | August 24, 2017 |
|
||
107 | NCT03109626 | Active, not recruiting | Docosahexaenoic Acid (DHA) Replacement for Treatment in Spinocerebellar Ataxia 38 |
|
|
Interventional | Not Applicable |
|
Other |
|
|
10 | All | 18 Years and older (Adult, Senior) | NCT03109626 | CE NP1821 | SCA38DHA | June 17, 2015 | September 17, 2015 | August 30, 2018 | April 12, 2017 | May 22, 2017 |
|
|
108 | NCT03120013 | Active, not recruiting | Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative Ataxia |
|
|
Interventional | Not Applicable |
|
Other |
|
|
21 | All | 18 Years and older (Adult, Senior) | NCT03120013 | NP1576 | CStDCSAtaxia | February 6, 2017 | December 1, 2018 | December 23, 2018 | April 19, 2017 | September 6, 2017 |
|
|
109 | NCT02600078 | Unknown † | The Evaluation of a Mobile Device to Measure Ataxia With High Altitude Exposure |
|
|
Interventional | Not Applicable |
|
Other |
|
|
16 | All | 18 Years to 45 Years (Adult) | NCT02600078 | H15-02093 | November 2015 | April 2016 | December 2016 | November 9, 2015 | November 18, 2015 |
|
||
110 | NCT02345135 | Completed | Susceptibility to Infections in Ataxia Telangiectasia |
|
|
Interventional | Not Applicable |
|
Other / Industry |
|
|
41 | All | 2 Years to 45 Years (Child, Adult) | NCT02345135 | INFECTION_AT2012 | September 2012 | January 31, 2016 | July 31, 2016 | January 26, 2015 | November 30, 2017 | |||
111 | NCT02440763 | Recruiting | The EUROSCA Natural History Study |
|
Observational |
|
Other |
|
|
400 | All | 18 Years and older (Adult, Senior) | NCT02440763 | 010/05 | EUROSCA-NHS | July 2005 | July 2050 | July 2050 | May 12, 2015 | June 29, 2017 |
|
|||
112 | NCT02906046 | Completed | Weight in Lower Limbs Improves Gait Ataxia of in Machado-Joseph Disease Patients |
|
|
Interventional | Not Applicable |
|
Other |
|
|
20 | All | 18 Years to 65 Years (Adult) | NCT02906046 | 989/12 | April 2012 | February 2014 | July 2014 | September 19, 2016 | September 19, 2016 | |||
113 | NCT02770807 | Recruiting | EDS in Ataxia Telangiectasia Patients |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
180 | All | 6 Years and older (Child, Adult, Senior) | NCT02770807 | IEDAT-02-2015 | ATTeST | March 2, 2017 | August 2018 | March 2019 | May 12, 2016 | October 31, 2017 |
|
|
114 | NCT00950196 | Completed | Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia |
|
|
Interventional | Phase 4 |
|
Other |
|
|
30 | All | 4 Years to 50 Months (Child) | NCT00950196 | SHEBA-08-5196-AN-CTIL | November 2008 | November 2009 | November 2009 | July 31, 2009 | June 28, 2011 |
|
||
115 | NCT02867969 | Recruiting | Slowing Down Disease Progression in Premanifest SCA: a Piloting Interventional Exergame Trial |
|
|
Interventional | Not Applicable |
|
Other |
|
|
26 | All | 18 Years to 80 Years (Adult, Senior) | NCT02867969 | SlowSCA | SlowSCA | August 2016 | February 2017 | May 2017 | August 16, 2016 | August 16, 2016 |
|
|
116 | NCT00692861 | Completed | Autoimmunity in Neurologic Complications of Celiac Disease |
|
Observational |
|
NIH |
|
|
14 | All | 18 Years to 100 Years (Adult, Senior) | NCT00692861 | 080153 08-N-0153 |
June 2, 2008 | January 3, 2014 | June 6, 2008 | April 20, 2018 |
|
|||||
117 | NCT00584948 | Completed Has Results |
Memantine Treatment in Fragile X-Associated Tremor/Ataxia Syndrome |
|
|
Interventional | Not Applicable |
|
Other / NIH / Industry |
|
|
94 | All | 30 Years to 80 Years (Adult, Senior) | NCT00584948 | 200715426-1 1RL1AG032115-01 |
September 2007 | September 2012 | September 2012 | January 2, 2008 | May 30, 2017 | April 10, 2017 |
|
|
118 | NCT02197104 | Completed | Citocoline for Treatment of FXTAS |
|
|
Interventional | Phase 2 |
|
Other |
|
|
10 | All | 18 Years to 90 Years (Adult, Senior) | NCT02197104 | CITO-123 | January 2015 | January 2017 | January 2017 | July 22, 2014 | August 30, 2017 |
|
||
119 | NCT01255358 | Completed | Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Teleangiectasia Patients |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
22 | All | 3 Years and older (Child, Adult, Senior) | NCT01255358 | IEDAT 01 | IEDAT01 | February 2011 | September 2011 | December 2011 | December 7, 2010 | December 29, 2011 |
|
|
120 | NCT02175290 | Recruiting | Machado-Joseph Disease in Israel |
|
Observational |
|
Other |
|
|
250 | All | 18 Years and older (Adult, Senior) | NCT02175290 | MMC140006CTIL | June 2014 | June 2017 | June 2018 | June 26, 2014 | March 16, 2017 |
|
||||
121 | NCT02333305 | Completed | Evolution of Albumin on AOA1 Patients Supplemented With Coenzyme Q10 |
|
|
Interventional | Phase 3 |
|
Other |
|
|
19 | All | 18 Years and older (Adult, Senior) | NCT02333305 | P081107 | AOA1 | June 2013 | September 2017 | September 2017 | January 7, 2015 | November 6, 2017 |
|
|
122 | NCT03487367 | Not yet recruiting New |
Clinical Trial Readiness for SCA1 and SCA3 |
|
Observational |
|
Other |
|
|
200 | All | 18 Years to 65 Years (Adult) | NCT03487367 | Pro00017836 U01 - Ashizawa 2016 |
May 31, 2018 | December 2022 | December 2022 | April 4, 2018 | April 10, 2018 | |||||
123 | NCT01589809 | Active, not recruiting | Effect of Nicotinamide in Friedreich's Ataxia |
|
|
Interventional | Phase 2 |
|
Other |
|
|
40 | All | 18 Years and older (Adult, Senior) | NCT01589809 | CR01849 | June 2012 | June 2015 | December 2017 | May 2, 2012 | July 2, 2017 |
|
||
124 | NCT02147886 | Completed | Study To Assess Safety, Tolerability and Efficacy of Intravenous Cabaletta in Patients With Machado-Joseph Disease |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
15 | All | 18 Years to 75 Years (Adult, Senior) | NCT02147886 | BB-MJD-201 | July 2014 | October 2016 | November 2016 | May 28, 2014 | November 22, 2016 |
|
||
125 | NCT00521469 | Completed | A Randomized Controlled Single-Blind Study of the Effects of Instrument-Applied Spinal Manipulative Therapy on Postural Control |
|
|
Interventional | Phase 2 |
|
Other |
|
All | 18 Years to 60 Years (Adult) | NCT00521469 | RD0750805694 | March 2007 | March 2008 | March 2008 | August 28, 2007 | October 17, 2008 |
|
||||
126 | NCT03408080 | Active, not recruiting | An Open Pilot Trial of BHV-4157 |
|
|
Interventional | Phase 3 |
|
Other |
|
|
24 | All | 18 Years to 75 Years (Adult, Senior) | NCT03408080 | 17-001508 | December 15, 2017 | May 2018 | January 2019 | January 23, 2018 | January 24, 2018 |
|
||
127 | NCT02857894 | Recruiting | Genetic Factors of Idiopathic Polypoidal Vasculopathies in the ATM Gene (Ataxia Telangiectasia Mutated) |
|
Observational |
|
Other |
|
|
40 | All | 18 Years and older (Adult, Senior) | NCT02857894 | MMT_2015_4 | ATM | November 5, 2015 | May 2018 | May 2018 | August 5, 2016 | March 1, 2018 |
|
|||
128 | NCT00136630 | Unknown † | Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations |
|
Observational |
|
Other |
|
225 | All | 18 Years to 80 Years (Adult, Senior) | NCT00136630 | RBM01-59 _ AOM03059 | May 2005 | December 2012 | August 29, 2005 | January 31, 2012 |
|
||||||
129 | NCT01428544 | Completed | Special Drug Use Investigation (Retrospective) for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg) |
|
|
Observational |
|
Industry |
|
|
5 | All | Child, Adult, Senior | NCT01428544 | 115490 | March 2012 | June 2015 | June 2015 | September 5, 2011 | July 15, 2015 | ||||
130 | NCT01428531 | Completed | Special Drug Use Investigation for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment |
|
|
Observational |
|
Industry |
|
|
200 | All | Child, Adult, Senior | NCT01428531 | 115489 | January 2012 | June 2015 | June 2015 | September 5, 2011 | July 15, 2015 | ||||
131 | NCT03285204 | Recruiting | Relationship Between Neurological Disability and Visual Impairment in Patients With ALS or Friedreich's Ataxia |
|
Observational |
|
Other |
|
|
90 | All | 18 Years and older (Adult, Senior) | NCT03285204 | ELA-AF-OCT-2014-01 | July 2015 | June 2018 | December 2019 | September 15, 2017 | April 10, 2018 |
|
||||
132 | NCT00272272 | Completed | Fall Prevention in a Geriatric Nursing Home Setting Using the Music of Nolwenn Leroy |
|
|
Interventional | Not Applicable |
|
Other |
|
|
200 | All | 50 Years and older (Adult, Senior) | NCT00272272 | CI-01-01-06-01 | December 2005 | October 2006 | March 2007 | January 5, 2006 | January 27, 2016 |
|
||
133 | NCT01483937 | Completed Has Results |
Evaluation of a Sensory Enrichment Multimodal Device (SEMD) on Physical Therapy Patients With Disequilibrium |
|
|
Interventional | Not Applicable |
|
Industry |
|
|
32 | All | 21 Years to 84 Years (Adult, Senior) | NCT01483937 | 10-221:1.2 W81XWH-10-C-0184-01 |
SEMD | November 2011 | May 2013 | August 2013 | December 2, 2011 | June 27, 2014 | June 27, 2014 |
|
134 | NCT02936531 | Recruiting | Brain Network Activation and Gait and Posture in FXTAS |
|
Observational |
|
Other / Industry |
|
|
150 | All | 50 Years to 80 Years (Adult, Senior) | NCT02936531 | SHEBA-16-3940-SH-CTIL | FXTAS-BNA | November 1, 2016 | October 2018 | November 2020 | October 18, 2016 | August 8, 2017 |
|
|||
135 | NCT02353299 | Completed Has Results |
Assess the Effect of Zolpidem, Silenor & Placebo on Arousability, Ataxia/Balance & Cognition in Healthy Volunteers |
|
|
Interventional | Phase 4 |
|
Industry / Other |
|
|
52 | Male | 21 Years to 50 Years (Adult) | NCT02353299 | PT-D1402 | January 2015 | January 2016 | March 2016 | February 2, 2015 | January 2, 2018 | December 7, 2017 |
|
|
136 | NCT00559767 | Completed | Mapping of End Stage Renal Disease Genetic Susceptibility in African Americans by Admixture Linkage Disequilibrium |
|
Observational |
|
NIH | 2860 | All | 21 Years and older (Adult, Senior) | NCT00559767 | 999906210 06-C-N210 |
June 30, 2006 | April 10, 2012 | November 16, 2007 | July 2, 2017 |
|
|||||||
137 | NCT02594917 | Recruiting | Genetic and Environmental Determinants That Control Metabolism in Pulmonary Hypertension |
|
|
Observational |
|
Other |
|
|
20 | All | 18 Years to 60 Years (Adult) | NCT02594917 | PRO15070005 | October 2015 | May 2019 | May 2019 | November 3, 2015 | April 18, 2018 |
|
|||
138 | NCT01964664 | Completed | Mindfulness Meditation for Subjects With Severe Speech and Physical Impairments |
|
|
Interventional | Not Applicable |
|
Other |
|
|
8 | All | 18 Years to 75 Years (Adult, Senior) | NCT01964664 | 8912 | MSPi | January 2013 | October 2016 | October 2016 | October 17, 2013 | April 13, 2017 |
|
|
139 | NCT01970137 | Completed | A 24-week Open-label Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD) |
|
|
Interventional | Phase 3 |
|
Industry |
|
All | 20 Years and older (Adult, Senior) | NCT01970137 | KPS1304 | October 2014 | October 25, 2013 | April 18, 2016 |
|
||||||
140 | NCT01970124 | Completed | A Long-Term Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD) |
|
|
Interventional | Phase 3 |
|
Industry |
|
All | 20 Years and older (Adult, Senior) | NCT01970124 | KPS1303 | May 2015 | October 25, 2013 | April 18, 2016 |
|
||||||
141 | NCT02282514 | Recruiting | Stem Cell Transplantation for Stiff Person Syndrome (SPS) |
|
|
Interventional | Phase 1 Phase 2 |
|
Other |
|
|
40 | All | 18 Years to 60 Years (Adult) | NCT02282514 | DIAD.SPS.2014 | SPS | October 2014 | October 2020 | October 2021 | November 4, 2014 | March 29, 2018 |
|
|
142 | NCT02829268 | Recruiting | A Clinical Trial of Dantrolene Sodium in Pediatric and Adult Patients With Wolfram Syndrome |
|
|
Interventional | Phase 1 Phase 2 |
|
Other |
|
|
50 | All | 5 Years to 60 Years (Child, Adult) | NCT02829268 | 201607006 | January 2017 | December 2018 | March 2019 | July 12, 2016 | March 28, 2017 |
|
||
143 | NCT01970111 | Completed | An Extension Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD) |
|
|
Interventional | Phase 3 |
|
Industry |
|
All | 20 Years and older (Adult, Senior) | NCT01970111 | KPS1302 | July 2015 | October 25, 2013 | April 18, 2016 |
|
||||||
144 | NCT01970098 | Completed | A Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD) |
|
|
Interventional | Phase 3 |
|
Industry |
|
All | 20 Years and older (Adult, Senior) | NCT01970098 | KPS1301 | January 2015 | October 25, 2013 | April 18, 2016 |
|
||||||
145 | NCT02039206 | Completed | The Influence of Deep TMS on Cerebellar Signs in Patients With Machado Joseph Disease |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
20 | All | 20 Years to 80 Years (Adult, Senior) | NCT02039206 | MJD MEIR dTMS 0059-13-MMC |
February 2014 | February 2015 | June 2016 | January 17, 2014 | January 25, 2018 |
|
||
146 | NCT01845883 | Unknown † | Perceptual Decision Making Under Conditions of Visual Uncertainty |
|
|
Interventional | Not Applicable |
|
Other |
|
|
120 | All | 18 Years to 80 Years (Adult, Senior) | NCT01845883 | 12-001589 | April 2013 | December 2015 | December 2016 | May 3, 2013 | December 18, 2015 |
|
||
147 | NCT01793168 | Recruiting | Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford |
|
Observational |
|
Other |
|
|
20000 | All | Child, Adult, Senior | NCT01793168 | 03-10-014 Hypersomnia Foundation National Ataxia Foundation 4p- Support Group CdLS Foundation Hyperacusis Research Limited Kabuki Syndrome Network Kawasaki Disease Foundation Klippel-Feil Syndrome Freedom Leiomyosarcoma Direct Research MSS Support Group ML4 Foundation Stickler Involved People IWSA Soft Bones PWN4PWN aHUS Klippel-Feil Syndrome Alliance American MEN Support Kleine-Levin Syndrome All Things Kabuki WSS Foundation BIVA ABDA PROS Foundation (HLH) |
CoRDS | July 2010 | December 2100 | December 2100 | February 15, 2013 | October 2, 2017 |
|
|||
148 | NCT00034242 | Completed | High-Dose Intravenous Immunoglobulin to Treat Cerebellar Degeneration |
|
|
Interventional | Phase 2 |
|
NIH |
|
20 | All | Child, Adult, Senior | NCT00034242 | 020185 02-N-0185 |
April 2002 | February 2004 | April 24, 2002 | March 4, 2008 |
|
||||
149 | NCT00001324 | Completed | PET Scan to Study Brain Control of Human Movement |
|
Observational |
|
NIH | 510 | All | Child, Adult, Senior | NCT00001324 | 920119 92-N-0119 |
March 1992 | July 2001 | December 10, 2002 | March 4, 2008 |
|
|||||||
150 | NCT03269201 | Not yet recruiting | Brain Network Activation in Patients With Movement Disorders |
|
Observational |
|
Other |
|
|
300 | All | 18 Years to 85 Years (Adult, Senior) | NCT03269201 | 4408-17 | BNA-MDi | September 15, 2017 | September 15, 2020 | September 15, 2022 | August 31, 2017 | August 31, 2017 |
† Study has passed its completion date and status has not been verified in more than two years.